Vera Therapeutics Files Definitive Proxy Statement
Ticker: VERA · Form: DEF 14A · Filed: Apr 3, 2025 · CIK: 1831828
| Field | Detail |
|---|---|
| Company | Vera Therapeutics, INC. (VERA) |
| Form Type | DEF 14A |
| Filed Date | Apr 3, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, governance
Related Tickers: VERA
TL;DR
Vera Therapeutics (VERA) filed its proxy statement for the May 14th meeting. Get ready to vote!
AI Summary
Vera Therapeutics, Inc. filed its definitive proxy statement (DEF 14A) on April 3, 2025, for its annual meeting on May 14, 2025. The filing details information for shareholders regarding the company's governance and upcoming votes. The company is based in Brisbane, California, and operates in the pharmaceutical preparations sector.
Why It Matters
This filing provides shareholders with essential information to make informed decisions at the upcoming annual meeting, impacting the company's future direction and governance.
Risk Assessment
Risk Level: low — This is a routine proxy filing, providing information to shareholders rather than announcing new material events.
Key Players & Entities
- Vera Therapeutics, Inc. (company) — Registrant
- 0001140361-25-012034 (filing_id) — Accession Number
- 20250403 (date) — Filing Date
- 20250514 (date) — Meeting Date
- 2000 SIERRA POINT PARKWAY, SUITE 1200 (address) — Business Address
- BRISBANE (location) — City
- CA (location) — State
- 94005 (zip_code) — Business Zip Code
- 650-770-0077 (phone_number) — Business Phone
FAQ
What is the purpose of this DEF 14A filing?
The purpose of this DEF 14A filing is to provide shareholders with information for the upcoming annual meeting, including details on company governance and matters to be voted upon.
When is Vera Therapeutics' annual meeting scheduled?
The annual meeting for Vera Therapeutics is scheduled for May 14, 2025.
What is Vera Therapeutics' primary business sector?
Vera Therapeutics, Inc. operates in the Pharmaceutical Preparations sector, with SIC code 2834.
Where is Vera Therapeutics headquartered?
Vera Therapeutics, Inc. is located at 2000 Sierra Point Parkway, Suite 1200, Brisbane, CA 94005.
What is the filing date of this proxy statement?
This definitive proxy statement (DEF 14A) was filed on April 3, 2025.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 3, 2025 regarding Vera Therapeutics, Inc. (VERA).